Cleared Traditional

K844877 - HEPES BUFFER IM IN NORMAL SALINE (FDA 510(k) Clearance)

Class I Pathology device.

K844877 · Hazleton Research Products, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1985
Decision
70d
Days
Class 1
Risk

K844877 is an FDA 510(k) clearance for the HEPES BUFFER IM IN NORMAL SALINE. Classified as Formulations, Balanced Salt Solutions (product code KIP), Class I - General Controls.

Submitted by Hazleton Research Products, Inc. (Denver, US). The FDA issued a Cleared decision on February 25, 1985 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.2875 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hazleton Research Products, Inc. devices

Submission Details

510(k) Number K844877 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 1984
Decision Date February 25, 1985
Days to Decision 70 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 77d · This submission: 70d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KIP Formulations, Balanced Salt Solutions
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.2875
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.